ClinicalTrials.Veeva

Menu

Cracking Consciousness Study With Monroe & Neuphoria (Cohort 2&3)

E

Efforia, Inc

Status

Enrolling

Conditions

Mental Health

Treatments

Device: Neuphoria Wearable

Study type

Interventional

Funder types

Industry

Identifiers

NCT07298369
45835 (Other Identifier)

Details and patient eligibility

About

In partnership with Monroe, this EEG neurofeedback study is looking at the efficacy of Neuphoria with Monroe for mental clarity and well-being.

Full description

This remotely administered decentralized trial is designed to explore the efficacy of the Neuphoria neurofeedback device in enhancing cognitive performance and achieving peak mental states through advanced EEG technology. By monitoring brainwave activity in real-time, this trial aims to provide personalized feedback to participants, enabling them to train their brains for improved focus, creativity, and flow states. The device serves as a comprehensive brain optimization platform, offering personalized assessments, data-driven insights, and actionable recommendations for mental well-being.

In an era where mindfulness and meditation are highly valued, yet rarely quantified, this study collaborates with Neuphoria to venture into measuring higher states of consciousness, blending scientific rigor with the art of introspection. The objective is to transform beliefs and anecdotal evidence about consciousness and mental wellness into empirical data, thereby redefining our understanding of mental health.

Participants in this study are guided through an exploration of their mental landscapes, with the goal of capturing data that reflects their journey towards higher consciousness. Through engagement with meditation and mindfulness techniques, participants will be able to gain insights into their stress levels and mindfulness tendencies. These insights will be quantified through established tools such as the Perceived Stress Scale and the Freiburg Mindfulness Inventory, offering a structured pathway to personal mental wellness enhancement and elevated consciousness.

The primary aim of this trial is to objectively measure shifts in consciousness in participants using EEG data, in conjunction with traditional mindfulness and stress metrics. By providing personalized insights into how meditation and mindfulness practices affect mental health, the study empowers participants to make informed decisions about their self-care routines and investments in personal development.

The significance of this study lies in its potential to convert subjective experiences of meditation into objective, quantifiable data. This endeavor bridges the gap between belief and measurable outcomes, advancing our understanding of how mindfulness practices influence consciousness and mental health. While acknowledging the limitations in the universal applicability of the results, the personalized insights gleaned from this study promise to be invaluable for participants eager to deepen their mindfulness practice and achieve a state of equanimity. Through this remotely conducted trial, we aim not only to explore the boundaries of mental wellness but also to offer a scientifically grounded pathway for individuals seeking to optimize their mental states.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Can read and understand English.
  • US resident.
  • Willing and able to follow the requirements of the protocol.

Exclusion criteria

  • Individuals with severe mental health disorders
  • Individuals with low frustration tolerance
  • Individuals without access to emergency medical care
  • Individuals involved in regulated professions
  • Individuals with skepticism towards digital monitoring
  • Individuals without a support system

Trial design

Primary purpose

Health Services Research

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Single arm where participants act as their own control
Experimental group
Description:
Single arm where participants act as their own control
Treatment:
Device: Neuphoria Wearable

Trial contacts and locations

1

Loading...

Central trial contact

Matthew Amsden

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems